Shu-Chen Lin Selected Research

WHI P154

8/2011

Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shu-Chen Lin Research Topics

Disease

4	Neoplasms (Cancer) 01/2016 - 06/2006
3	Lung Neoplasms (Lung Cancer) 08/2011 - 06/2006
2	Neoplasm Metastasis (Metastasis) 08/2011 - 01/2007
1	Obesity 05/2023
1	Pain (Aches) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2008
1	Xerostomia 08/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2006
1	Carcinogenesis 06/2006

Drug/Important Bio-Agent (IBA)

1	Freund's AdjuvantIBA 01/2020
1	LuteolinIBA 01/2016
1	WHI P154IBA 08/2011
1	NVP-TAE684IBA 08/2011
1	Anaplastic Lymphoma KinaseIBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	ParaffinIBA 01/2007
1	ErbB Receptors (EGF Receptor)IBA 01/2007
1	InterferonsIBA 06/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2006

Therapy/Procedure

1	Kidney Transplantation 05/2023
1	Oral Administration 01/2020
1	Radiotherapy 08/2008
1	Therapeutics 01/2007